The Wall Street Journal Online:
Monday November 23, 2009 9:21 AM ET
-
Bank Notes | College Planning | Debt | Elder Care | Employment | Estate Planning | Health Care | Insurance | Marriage & Divorce | Real Estate | Retirement | Taxes
-
Share Price ($):
6.46Price Change:
0.00 (0.00%)
Last 10 Quotes
What is this?
ELN
(ELAN CORP PLC)
Exchange: NYSE
Industry: Drug Delivery
Last Trade 4:03 PM ET 11/20/2009
 |
 |
| Volume: | NA |
|---|---|
| Day's Low: | NA |
| 52-wk Low: | $4.61 |
| Previous Close: | $6.46 |
| Dividend: | $1.15 |
| Market Cap: | 3,045,300 |
| Avg Volume: | 4,766,000 |
|---|---|
| Day's High: | NA |
| 52-wk High: | $9.13 |
| Open Price: | NA |
| Yield: | 0.00% |
| P/E (Forward): | NA |
Breaking News
| 4:15 PM | 11/20/2009 | UPDATE: HealthCor Urges Biogen Board Consider Number Of Changes |
| 12:18 PM | 11/20/2009 | HealthCor Urges Biogen Board Consider Number Of Changes |
| 7:53 PM | 11/11/2009 | Biogen Rethinking Disclosure Policies On MS Drug Tysabri |
| 6:16 PM | 11/11/2009 | 2nd UPDATE: Biogen, Elan, Roche In Brain Infection Consortium |
| 2:38 PM | 11/11/2009 | UPDATE: Biogen, Elan, Roche Forming Brain Infection Consortium |
| 12:58 PM | 11/11/2009 | Biogen, Elan, Roche Form Consortium To Study Brain Infection |
| 5:53 PM | 11/6/2009 | Biogen Updates Tysabri Label To Reflect Risk With Longer Use |
Stories & Blogs: Around the Web
| 11/11/2009 | When Rival Drug Makers Compare Notes On Safety Problems |
| 11/3/2009 | Johnson & Johnson to cut up to 8,200 jobs |
| 10/26/2009 | J&J CEO's Lower-Risk Alternative to Acquisitions |
| 10/23/2009 | Elan, Ramtron International: Biggest Price Decliners (ELN, RMTR) |
| 10/21/2009 | Updates, advisories and surprises |
| 10/13/2009 | Medical Devices Boost J&J's Net |
| 10/13/2009 | J&J Is Still OK |
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | -0.06 | -0.18 | 66.67 |
| EPS, GAAP | 0.11 | -0.18 | NA |
| Consensus Estimate | -0.14 | -0.13 | -7.69 |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | -0.53 | -0.64 | 17.19 |
| EPS, GAAP | -0.18 | -0.69 | 73.91 |
| Consensus Estimate | -0.53 | NA | NA |
| ELN | Industry Average | |
| P/E (TTM) | -35.89 | 23.70 |
| P/E (Forward) | NA | 1.10 |
| PEG Ratio | NA | 0.07 |
| Price/Sales | 2.88 | 2.45 |
| Beta | 0.80 | 0.84 |
Advertisements
Hear our feeds on Jott
Post/View comments about this company
SmartMoney Mobile | Customer Service | Magazine Customer Service | Subscribe to SmartMoney Magazine | Your Profile | Contact Us
About Our Ads | Corrections | Custom Publishing | License Our Content | Media Kit | Press Room | Events | Site Map | Labs |
About Our Ads | Corrections | Custom Publishing | License Our Content | Media Kit | Press Room | Events | Site Map | Labs |
You Are Viewing: SmartMoney.com — Investing, Saving and Personal Finance.
